The unknown is one of the reasons for the pressure on the stock price. it will remain there until the market is told the problems and how it will take to fix. I expect when they disclose the issues and hopeful short timeframe to fix them, we will get a nice pop ($3, 4$?) I wouldn't be surprised if we move back above $10 after that conference call. That would be great if they know by the earnings conference in about two weeks. I hope they don't have to wait until mid-april to actually find out the issues. With that being said, they know about the requested extraction study and they should be working "expeditiously" on that now.
There has not been much talk here about that extraction study. To me, that seems pretty important to be able to prove the product can deliver the correct amount of drugs. CRMD thought they had that taken care of, but apparently not according to the FDA. I hope this "study" is not something that requires a bunch of time. Maybe it is just a matter of running the device a thousands times to see if it generates the same results. Any thoughts on this?